Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. MYONAL TABLET 50 MG [SIN06292P]

MYONAL TABLET 50 MG [SIN06292P]

Active ingredients: MYONAL TABLET 50 MG

Last updated 26 October 2025

Product Info

MYONAL TABLET 50 MG

[SIN06292P]

Product information

Active Ingredient and Strength

EPERISONE HCL - 50 MG

Dosage Form

TABLET, SUGAR COATED

Manufacturer and Country

BUSHU PHARMACEUTICALS LTD. - JAPAN

Registration Number

SIN06292P

Licence Holder

DKSH SINGAPORE PTE. LTD.

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

M03BX09

【INDICATIONS】

  • Improvement of myotonic conditions caused by the following diseases:

    Neck-shoulder-arm syndrome, scapulohumeral periarthritis and low back pain

  • Spastic paralysis caused by the following diseases:

    Cerebrovascular disorders, spastic spinal paralysis, cervical spondylosis, sequelae of surgical trauma (including cerebrospinal tumor), sequelae of trauma (spinal injury and head injury), amyotrophic lateral sclerosis, infantile cerebral palsy, spinocerebellar degeneration, spinal vascular disorder, subacute myelo-optico neuropathy (SMON) and other encephalomyelopathies

【DOSAGE AND ADMINISTRATION】
The usual adult dosage for oral use is 3 tablets (150 mg of eperisone hydrochloride) daily in three divided doses after meals.
The dosage may be adjusted depending on the patient’s age and symptoms.

【CONTRAINDICATIONS】
(MYONAL is contraindicated in the following patients.)
Patients with a history of hypersensitivity to any ingredients of MYONAL.